Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Neurosteroids show promise for treating epilepsy and more research is needed.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Certain drugs that block specific enzymes can help treat prostate diseases.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Stump-tailed macaque best for researching hair loss causes and treatments.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

DHT stops hair regrowth in mice, similar to human hair loss.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.